Advanced search×


Print ISSN
Electronic ISSN
Impact factor
Usage rank
Article count
Free count
Free percentage
PDFs via platforms
Ovid from 2001 and LWW

  1. Deferoxamine-related ocular toxicity: incidence and outcome in a pediatric population.

    Retina 28(6):894 (2008) PMID 18536609

    Deferoxamine (DFO) is a chelating agent used widely for the treatment of transfusional hemochromatosis. DFO-related ocular toxicity has been previously reported several times, and many institutions have adopted an ophthalmic screening protocol for patients treated with DFO despite little informa...
  2. Abnormal macular pigment distribution in type 2 idiopathic macular telangiectasia.

    Retina 28(6):808 (2008) PMID 18536596

    To determine the distribution of macular pigment in type 2 idiopathic macular telangiectasia (IMT). Twenty-two eyes of 12 patients with type 2 IMT were examined by means of best-corrected visual acuity testing, fundus biomicroscopy, fundus photography, fluorescein angiography, and optical cohere...
  3. Pediatric rhegmatogenous retinal detachment: clinical features and surgical outcomes.

    Retina 28(6):847 (2008) PMID 18536601

    To describe the characteristics of and surgical outcomes for primary pediatric rhegmatogenous retinal detachment (RRD) and to evaluate whether specific characteristics impact anatomical outcomes after surgical intervention. Data for consecutive patients (18 years of age or younger) with RRD who ...
  4. The optical coherence tomography-ophthalmoscope for examination of central serous chorioretinopathy with precipitates.

    Retina 28(6):864 (2008) PMID 18536604

    To report the exact location of multiple yellowish dot-like precipitates in central serous chorioretinopathy (CSC) with the Optical Coherence Tomography (OCT)-Ophthalmoscope (Nidek-OTI, Gamagori, Japan). Retrospective, observational study. Twenty eyes of 18 patients (average age, 53 years) with ...
  5. The effect of treatments given to patients before initiation of anti-vascular endothelial growth factor treatment.

    Retina 28(6):911 (2008) PMID 18536615

  6. Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone I or posterior zone II.

    Retina 28(6):831 (2008) PMID 18536599

    To report a retrospective, consecutive, noncomparative case series of moderate and severe stage 3 retinopathy of prematurity (ROP) in zone I or posterior zone II treated by bilateral intravitreal injections of bevacizumab (Avastin; Genentech, Inc., South San Francisco, CA). Eleven infants weighi...
  7. Proinflammatory cytokines and angiogenic and anti-angiogenic factors in vitreous of patients with proliferative diabetic retinopathy and eales' disease.

    Retina 28(6):817 (2008) PMID 18536597

    To investigate the mechanism of angiogenesis in proliferative diabetic retinopathy (PDR) and Eales' disease (ED) on the basis of the levels of proinflammatory cytokines, angiogenic growth factor, and antiangiogenic factor in the vitreous humor. Twenty-five patients with PDR, 10 patients with ED,...
  8. Lipocalin-like prostaglandin D synthase in subretinal fluid of detached retinas in humans.

    Retina 28(6):858 (2008) PMID 18536603

    The presence of lipocalin-like prostaglandin D synthase (L-PGDS), a dominantly brain derived protein in the cerebrospinal fluid (CSF) with a low concentration in serum, in the subretinal fluid (SRF) of detached retinas, has not been reported. L-PGDS has been demonstrated in the ciliary body and ...
  9. The use of intravitreal bevacizumab to treat choroidal neovascular membranes (CNVMs).

    Retina 28(6):910; author reply 910 (2008) PMID 18536613

  10. A method of reporting macular edema after cataract surgery using optical coherence tomography.

    Retina 28(6):870 (2008) PMID 18536605

    To validate a method of reporting postcataract macular edema (ME) using optical coherence tomography (OCT). : Data were analyzed for 130 eyes followed prospectively for ME after uncomplicated cataract surgery. Each eye underwent OCT within 4 weeks before surgery and at 1 month and 3 months after...